Clinical Study

The Impact of Multiple Malignancies on Patients with Bladder Carcinoma: A Population-Based Study Using the SEER Database

Table 5

(a) Time between bladder and nonbladder cancer diagnoses

Patient cohortMean time between diagnoses ± SD (months)

ABOverall 5 1 . 0 0 ± 6 1 . 8 0
Low stage only 4 8 . 6 0 ± 6 0 . 4 8
High-stage only 5 9 . 5 2 ± 6 5 . 6 4
BSOverall 5 6 . 2 8 ± 6 3 . 4 8
Low stage only 6 3 . 3 6 ± 6 5 . 8 8
High-stage only 2 9 . 1 6 ± 5 1 . 3 6

𝑃 < . 0 0 1 for all intergroup comparisons.
(b) Time to death following diagnosis of bladder cancer

Patient cohortMean time to death following
bladder cancer diagnosis (months)

BO64.30
AB43.21
BS91.80
ABS62.80

𝑃 < . 0 0 1 for all intergroup comparisons.